[Cotrimoxazole Pneumocystis jiroveci pneumonia treatment failure: co-infection cytomegalovirus role?]

Ann Fr Anesth Reanim. 2007 Jun;26(6):604-7. doi: 10.1016/j.annfar.2007.02.020. Epub 2007 Apr 12.
[Article in French]

Abstract

Pneumocystis jiroveci pneumonia is a classic opportunist infection affecting AIDS patients. However it is less frequent since systematic prophylaxis and antiretroviral therapies. Treatment resistance is rare in France. We report the case of a severe Pneumocystis jiroveci pneumonia with treatment resistance to standard treatment and fatal outcome. The different causes of treatment resistance, notably the role of CMV co-infection, were reviewed and discussed.

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Cytomegalovirus Infections / complications*
  • Drug Resistance, Bacterial
  • Fatal Outcome
  • Humans
  • Male
  • Middle Aged
  • Pneumocystis carinii*
  • Pneumonia, Pneumocystis / drug therapy*
  • Pneumonia, Pneumocystis / virology*
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology*

Substances

  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination